The Congolese government announced late Sunday that the country has now recorded 1,274 confirmed Ebola cases, with 360 people having died from the deadly virus.
In response to the worsening outbreak, the U.S. Centers for Disease Control and Prevention (CDC) on Friday activated a Level 1 response—its highest internal emergency status—and confirmed that experimental Ebola treatments are being shipped to affected areas in Congo to support ongoing containment efforts.
Despite the escalation, U.S. health officials stressed that the outbreak does not currently pose a significant threat to the American public.
"Our assessment (is) that the risk to the United States continues to remain low," said Satish Pillai, who is leading the Ebola response at the Centers for Disease Control and Prevention (CDC).
Highest Alert Signals Priority Response
The CDC explained that activating a Level 1 response does not necessarily indicate a heightened risk to the United States but serves as an internal measure that places the outbreak among the agency's highest operational priorities.
The agency previously activated the same level of response during the devastating 2014 Ebola epidemic in West Africa, the largest outbreak of the disease ever recorded.
According to a CDC official, the heightened response level is an "internal cue" that allows the agency to rapidly deploy personnel, technical expertise and financial resources to support the international response.
"We will mobilize staffing and additional resources as efficiently and rapidly as possible," the official added.
International Efforts Intensify
The shipment of experimental treatments forms part of broader international efforts to curb the spread of Ebola, a highly infectious viral disease that can cause severe fever, internal bleeding and multiple organ failure.
Public health experts have continued to emphasize that early detection, rapid isolation of infected patients, contact tracing and access to treatment remain the most effective tools for controlling outbreaks.
While health authorities remain focused on containing the virus within affected regions of the Democratic Republic of Congo, global health agencies continue to monitor the situation closely to prevent cross-border transmission and strengthen preparedness in neighbouring countries.